Literature DB >> 29893826

Systematic review and meta-regressions: management of eosinophilic esophagitis requires histologic assessment.

J W Chang1, R Y Yeow2, A K Waljee1,3, J H Rubenstein1,3.   

Abstract

Treatment endpoints in eosinophilic esophagitis (EoE) are response of eosinophilic inflammation and of symptoms. Steroids and diet therapy are effective in inducing histologic response in EoE, but there may be poor correlation between histologic and symptomatic response. Despite this, we find that in clinical practice symptoms are commonly used to guide management without assessing histologic response. We hypothesized that symptom response alone is not reliable in assessing response to therapy and is confounded by endoscopic dilation. We conducted a systematic review and meta-regressions to estimate the association of histologic and symptomatic response, stratified by whether concurrent dilation was permitted. We performed a systematic search of PubMed, EMBASE, and Web of Science for studies describing both histologic and symptomatic responses to dilation, steroid, and diet therapies. We abstracted the proportion of histologic response and symptom response. Studies were stratified by whether dilation was permitted. We performed meta-regressions of the association between the proportions with histologic and symptomatic response, stratified by whether dilation was permitted. We identified 1359 articles, of which 62 articles were assessed for eligibility, and 23 were included providing data on 1202 patients with EoE. Unstratified meta-regression of histologic versus symptomatic response showed moderate association and large heterogeneity (inconsistency index [I2] = 89%). In adult studies in which dilation was allowed, there was weak association between symptomatic and histologic response (β1 = 0.21), minimal symptomatic response of 67% and the heterogeneity persisted, I2 = 77%. In studies that prohibited dilation, maximal symptomatic response was 72% and was moderately associated with histologic response (β1 = 0.39) with less heterogeneity, I2 = 59%. Studies of EoE that permit dilation obscure the relation between histologic and symptomatic response and have a high floor effect for symptomatic response. Studies that prohibit dilation demonstrate moderate association between histologic and symptomatic response, but have a ceiling effect for symptomatic response. Our results demonstrate that success of dietary or medical management for EoE cannot be judged by symptoms alone, and require histologic assessment, particularly if dilation has been performed.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29893826      PMCID: PMC9118332          DOI: 10.1093/dote/doy049

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   2.822


  30 in total

1.  Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.

Authors:  Ranjan Dohil; Robert Newbury; Lyman Fox; John Bastian; Seema Aceves
Journal:  Gastroenterology       Date:  2010-05-07       Impact factor: 22.682

2.  Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate.

Authors:  Matthew Remedios; Catherine Campbell; Dianne M Jones; Paul Kerlin
Journal:  Gastrointest Endosc       Date:  2006-01       Impact factor: 9.427

3.  Cow's milk elimination: a novel dietary approach to treat eosinophilic esophagitis.

Authors:  Amir F Kagalwalla; Katie Amsden; Ameesh Shah; Sally Ritz; Maria Manuel-Rubio; Katherine Dunne; Suzanne P Nelson; Barry K Wershil; Hector Melin-Aldana
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-12       Impact factor: 2.839

4.  A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis.

Authors:  Michael R Konikoff; Richard J Noel; Carine Blanchard; Cassie Kirby; Sean C Jameson; Bridget K Buckmeier; Rachel Akers; Mitchell B Cohen; Margaret H Collins; Amal H Assa'ad; Seema S Aceves; Philip E Putnam; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2006-08-16       Impact factor: 22.682

5.  Comparisons of Fluticasone to Budesonide in the Treatment of Eosinophilic Esophagitis.

Authors:  Dustin Albert; Theresa A Heifert; Steve B Min; Corinne L Maydonovitch; Thomas P Baker; Yen-Ju Chen; Fouad J Moawad
Journal:  Dig Dis Sci       Date:  2016-04-19       Impact factor: 3.199

6.  Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children.

Authors:  Elizabeth T Schaefer; Joseph F Fitzgerald; Jean P Molleston; Joseph M Croffie; Marian D Pfefferkorn; Mark R Corkins; Joel D Lim; Steven J Steiner; Sandeep K Gupta
Journal:  Clin Gastroenterol Hepatol       Date:  2008-02       Impact factor: 11.382

7.  Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: The 2-4-6 study.

Authors:  Javier Molina-Infante; Ángel Arias; Javier Alcedo; Ruth Garcia-Romero; Sergio Casabona-Frances; Alicia Prieto-Garcia; Ines Modolell; Pedro L Gonzalez-Cordero; Isabel Perez-Martinez; Jose Luis Martin-Lorente; Carlos Guarner-Argente; Maria L Masiques; Victor Vila-Miravet; Roger Garcia-Puig; Edoardo Savarino; Carlos Teruel Sanchez-Vegazo; Cecilio Santander; Alfredo J Lucendo
Journal:  J Allergy Clin Immunol       Date:  2017-10-23       Impact factor: 10.793

8.  ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).

Authors:  Evan S Dellon; Nirmala Gonsalves; Ikuo Hirano; Glenn T Furuta; Chris A Liacouras; David A Katzka
Journal:  Am J Gastroenterol       Date:  2013-04-09       Impact factor: 10.864

9.  Elemental diet decreases inflammation and improves symptoms in adult eosinophilic oesophagitis patients.

Authors:  M J Warners; B J Vlieg-Boerstra; J Verheij; B D van Rhijn; M T J Van Ampting; L F Harthoorn; W J de Jonge; A J P M Smout; A J Bredenoord
Journal:  Aliment Pharmacol Ther       Date:  2017-01-23       Impact factor: 8.171

10.  Savary Dilation Is Safe and Effective Treatment for Esophageal Narrowing Related to Pediatric Eosinophilic Esophagitis.

Authors:  Abdulrahman Al-Hussaini
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-11       Impact factor: 2.839

View more
  4 in total

1.  Management of eosinophilic esophagitis is often discordant with guidelines and not patient-centered: results of a survey of gastroenterologists.

Authors:  Joy W Chang; Sameer D Saini; Jessica L Mellinger; Joan W Chen; Brian J Zikmund-Fisher; Joel H Rubenstein
Journal:  Dis Esophagus       Date:  2019-06-01       Impact factor: 3.429

2.  Treatment with compounded fluticasone suspension improves the clinical, endoscopic, and histologic features of eosinophilic esophagitis.

Authors:  Corey J Ketchem; Craig C Reed; Zoe Stefanadis; Evan S Dellon
Journal:  Dis Esophagus       Date:  2021-07-12       Impact factor: 3.429

3.  Long-Lasting Dissociation of Esophageal Eosinophilia and Symptoms After Dilation in Adults With Eosinophilic Esophagitis.

Authors:  Ekaterina Safroneeva; Zhaoxing Pan; Eileen King; Lisa J Martin; Margaret H Collins; Guang-Yu Yang; Kelley E Capocelli; Nicoleta C Arva; J Pablo Abonia; Dan Atkins; Peter A Bonis; Evan S Dellon; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; Ikuo Hirano; John Leung; Paul A Menard-Katcher; Vincent A Mukkada; Alain M Schoepfer; Jonathan M Spergel; Barry K Wershil; Marc E Rothenberg; Seema S Aceves; Glenn T Furuta
Journal:  Clin Gastroenterol Hepatol       Date:  2021-05-29       Impact factor: 11.382

4.  Mental distress among adult patients with eosinophilic esophagitis.

Authors:  Willemijn E de Rooij; Floor Bennebroek Evertsz'; A Lei; Albert J Bredenoord
Journal:  Neurogastroenterol Motil       Date:  2020-12-31       Impact factor: 3.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.